NCT04386772 Portal Vein Embolization Using Coils Plus TAGM vs Multiple Coils for Patients With Perihilar Cholangiocarcinoma or Hepatocellular Carcinoma Status UNKNOWN Phase NA
NCT04374877 Study of CHS-388 (Formerly Known as SRF388) in Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT04368182 AFP Specific T Cell Receptor Transduced T Cells Injection(C-TCR055) in Unresectable Hepatocellular Carcinoma Status UNKNOWN Phase PHASE1
NCT04368078 Lenvatinib Combined Toripalimab in Advanced Hepatocellular Carcinoma Status UNKNOWN Phase PHASE2
NCT04367805 COVID-19 Infection in Patients With Hepatocellular Carcinoma Status ACTIVE_NOT_RECRUITING Phase N/A
NCT04365751 To Compare the Efficacy of Microwave Ablation and Laparoscopic Hepatectomy for Hepatocellular Carcinoma Status RECRUITING Phase NA
NCT04348838 Prospective Cohort of Patients With Hepatocellular Carcinoma in France Status RECRUITING Phase N/A
NCT04340986 Cohort of Patients With Hepatocellular Carcinoma or Cholangiocarcinoma Status RECRUITING Phase N/A
NCT04327700 Study Of Intrabucally Administered Electromagnetic Fields and Regorafenib Status TERMINATED Phase PHASE2
NCT04319484 Lenvatinib Following Liver Transplantation in Patients of Hepatocellular Carcinoma With Portal Vein Tumor Thrombus Status NOT_YET_RECRUITING Phase PHASE2/PHASE3
NCT04317248 "Cocktail" Therapy for Hepatitis B Related Hepatocellular Carcinoma Status UNKNOWN Phase PHASE2
NCT04316182 Cabozantinib in Patients With Hepatocellular Carcinoma (ACTION) Status COMPLETED Phase PHASE2
NCT04315883 Yttrium-90 (TARE-Y90) in Children, Adolescents, and Young Adults With Liver Tumors Status TERMINATED Phase N/A
NCT04310540 PSMA PET/MRI or PSMA PET/CT for Evaluation of Liver Cancer Status COMPLETED Phase EARLY_PHASE1
NCT04303286 The Effect of Gut Microbiota on Postoperative Liver Function Recovery in Patients With Hepatocellular Carcinoma Status COMPLETED Phase N/A
NCT04299919 The AI Prognostic Assessment and Pathological Basis Research of Early HCC After Minimally Invasive Treatment Status UNKNOWN Phase N/A
NCT04297280 TACE Combined with Anti-PD-1 Antibody in Patients with Advanced Hepatocellular Carcinoma Status COMPLETED Phase PHASE2
NCT04297202 SHR-1210 Combined With Apatinib Mesylate in the Perioperative Treatment of Hepatocellular Carcinoma Status UNKNOWN Phase PHASE2
NCT04282044 Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies Status RECRUITING Phase PHASE1